Latest Regulatory News

Page 159 of 888
Halo Technologies Holdings Ltd posted a $17.4 million loss for 2025, widening from $14.5 million the previous year, as revenue fell 16%. The company completed a $3.9 million rights issue and announced a strategic pivot in its UK operations.
Claire Turing
Claire Turing
27 Feb 2026
Codeifai Limited reported a 26% revenue decline to $598,497 for 2025 alongside a sharp increase in net loss to $6.22 million, driven by strategic investments and market challenges. The company’s pivot to self-service SaaS platforms, including a key acquisition post-year-end, signals a transformative but uncertain path forward.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Beacon Minerals Limited has reported a robust half-year performance with gold sales more than doubling to AU$82.6 million and a comprehensive profit of AU$14.8 million, driven by strong production growth and higher gold prices.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Environmental Clean Technologies Limited reported a $2.58 million loss for the half-year ended December 2025, marking a strategic pivot with the acquisition of Terrajoule Pty Ltd and exclusive rights to innovative remediation technology.
Victor Sage
Victor Sage
27 Feb 2026
Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.
Ada Torres
Ada Torres
27 Feb 2026
AJ Lucas Group Limited has swung to a $38.9 million half-year profit, buoyed by a significant UK settlement and improved Australian drilling operations despite revenue pressures.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Insignia Financial Ltd shareholders are invited to vote on a $4.80 per share acquisition scheme by Daintree BidCo, an entity backed by CC Capital Partners LLC and affiliates. The Federal Court has approved the Scheme Meeting and the distribution of the Scheme Booklet, which includes an Independent Expert’s Report supporting the fairness and reasonableness of the offer.
Claire Turing
Claire Turing
27 Feb 2026
PainChek Limited reported a half-year loss of AUD 4.7 million but achieved a major regulatory milestone with FDA clearance for its Adult App, unlocking significant US market opportunities. The company also completed a share consolidation and raised capital to support growth.
Ada Torres
Ada Torres
27 Feb 2026
Radiopharm Theranostics reported a 44% increase in net loss to $27 million for the half-year ended December 2025, driven by expanded R&D spending. The company bolstered its cash reserves through a $35 million placement while progressing multiple clinical trials across its radiopharmaceutical pipeline.
Ada Torres
Ada Torres
27 Feb 2026
Racura Oncology reported a $4.1 million loss for H1 FY26, reflecting heavy investment in clinical trials and intellectual property. The company also boosted cash reserves through capital raises and rebranded from Race Oncology.
Ada Torres
Ada Torres
27 Feb 2026
Steamships Trading Company Limited reported a robust 46% rise in net profit for 2025, driven by strategic investments and operational improvements, while proposing a higher dividend despite ongoing ERP upgrade expenses.
Victor Sage
Victor Sage
27 Feb 2026
Investigator Silver Limited’s Definitive Feasibility Study confirms the Paris Silver Project as a high-margin, low-risk development with rapid payback and modest funding needs. The study outlines a conventional open-pit mine in South Australia, poised for near-term production with robust financial metrics.
Maxwell Dee
Maxwell Dee
27 Feb 2026